MANCUSO, GAIA
 Distribuzione geografica
Continente #
EU - Europa 56
AS - Asia 41
NA - Nord America 39
Totale 136
Nazione #
US - Stati Uniti d'America 39
CN - Cina 26
SE - Svezia 26
IT - Italia 17
SG - Singapore 10
RU - Federazione Russa 7
IN - India 3
UA - Ucraina 3
IR - Iran 2
DE - Germania 1
FI - Finlandia 1
GB - Regno Unito 1
Totale 136
Città #
Shanghai 15
New York 8
Singapore 8
Vaprio d'Adda 8
Milan 6
Boardman 4
Lawrence 4
Princeton 4
Bergamo 3
Kyiv 3
Moscow 3
Pune 3
Ashburn 2
Dallas 2
Ljungby 2
Helsinki 1
London 1
Los Angeles 1
Ma'anshan 1
Munich 1
Omsk 1
Xi'an 1
Totale 82
Nome #
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 25
Urgent manifestations of immunoglobulin G4-related disease 20
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 20
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 16
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 15
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 14
Colchicine as a new therapeutic option for antithyroid arthritis syndrome 14
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 11
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 10
Totale 145
Categoria #
all - tutte 1.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 1 1 1 0 0 0 0 0
2021/20224 0 0 0 1 0 0 0 0 1 2 0 0
2022/202355 9 8 4 0 0 4 22 7 0 0 1 0
2023/202453 0 6 0 7 3 11 1 11 0 1 5 8
2024/202530 10 5 7 3 5 0 0 0 0 0 0 0
Totale 145